期刊
CLINICAL INFECTIOUS DISEASES
卷 46, 期 4, 页码 567-570出版社
UNIV CHICAGO PRESS
DOI: 10.1086/526775
关键词
-
资金
- NIAID NIH HHS [T32 AI055435, K23-AI-060887-01] Funding Source: Medline
Eighteen patients received tigecycline as treatment for infection due to multidrug-resistant gram-negative bacilli, including Acinetobacter baumannii and Klebsiella pneumoniae carbapenemase - and extended-spectrum beta-lactamase-producing Enterobacteriaceae. Pretherapy minimum inhibitory concentration values for tigecycline predicted clinical success. Observed evolution of resistance during therapy raises concern about routine use of tigecycline in treatment of such infections when other therapies are available.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据